JP Morgan Chase’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,300
Closed -$117K 6601
2021
Q4
$117K Hold
13,300
﹤0.01% 5607
2021
Q3
$138K Buy
+13,300
New +$116K ﹤0.01% 5411

Other funds holding SRTA

JP Morgan Chase's SRTA Position: Q2 2026 in Review

JP Morgan Chase reduced its Strata Critical Medical Inc (SRTA) stake by 1.2% in Q2 2026, selling an estimated $20.4K and leaving 316,354 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #4339.

JP Morgan Chase first reported a position in SRTA in Q1 2020 and has held it in 22 quarters since. The position peaked at $3.19M in Q2 2024. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • JP Morgan Chase held 316,354 shares of Strata Critical Medical Inc worth $1.64M as of Q2 2026.
  • JP Morgan Chase sold 3,880 Strata Critical Medical Inc shares in Q2 2026, an estimated $20.4K.
  • Strata Critical Medical Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4339 holding.
  • JP Morgan Chase first reported a position in Strata Critical Medical Inc in Q1 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Strata Critical Medical Inc position peaked at $3.19M in Q2 2024.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.